type here...

CATEGORIES

Pharmaceutics

LATEST

1234...11Page 3 of 11

TRENDING

EDITORS CHOICE

TaiGen files US IND for its influenza antiviral TG-1000

Medika Life -
TaiGen Biotechnology Company, announced today that it has filed an IND application with the US FDA for its influenza antiviral TG-1000.

Does Pharma Need Independent DNA Oversight?

Robert Turner, Founding Editor -
Our survival as a species could be placed in jeopardy if we don't begin to police treatments that place our DNA in harms way. Oversight is needed.

FDA approves Ready-to-Use Ephedrine Injection, Emerphed™

Medika Life -
Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)

Vaccines and Mandates Could Be the Undoing of the Democratic Party

Robert Turner, Founding Editor -
This article refers to the Covid treatments as "vaccinations." It's important to note that these medical interventions are not vaccines at all. They do not prevent infection or transmission but rather life-protecting treatments designed to reduce the onset of severe symptoms, much like seasonal influenza shots.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories